Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Clinical characteristics of patients with heart failure and intracardiac thrombus

View through CrossRef
BackgroundHeart failure (HF) patients are in a hypercoagulable state that predisposes them to an intracardiac thrombus. We aim to assess the clinical features of patients with HF and intracardiac thrombus.MethodsPatients diagnosed with HF with intracardiac thrombus were enrolled in this study. Patients' demographics, clinical comorbidities, laboratory tests, and cardiac imaging parameters are recorded. Baseline characteristics are described; the relationship between intracardiac thrombus location and cardiac underlying diseases, New York Heart Association (NYHA) class, and left ventricular ejection fraction (LVEF) are analyzed; and the anticoagulation rate is summarized.ResultsA total of 1,248 patients were included in the study. Most patients were men (72.2%) with a mean age of 54 years. The left ventricle is the most frequently involved (66.8%), and the prevalence of left ventricular thrombus is more in patients complicated with coronary artery diseases, ventricular noncompaction cardiomyopathy, and dilated cardiomyopathy (86.3%, 86.4%, and 78.2%, respectively). When combined with atrial fibrillation, atrial flutter, hypertrophic cardiomyopathy, restrictive cardiomyopathy, or valvular cardiomyopathy, the intracardiac thrombus is mostly likely to occur in the left atrium. The incidence rate of left cardiac thrombosis increased with the decline of LVEF, an increase of NYHA class, and enlargement of a cardiac chamber. Overall, the anticoagulation rate was 56.8%, with warfarin still the mainstay drug (45.1%), while the prescription of non-vitamin K antagonist oral anticoagulants rose year by year. As for imaging modalities for thrombus detection and diagnosis, transthoracic echocardiography was the most widely performed (75.1%).ConclusionThis study summarizes the underlying disease constitution, thrombus location and related factors, imaging modalities, and antithrombotic profile in HF patients with intracardiac thrombus comprehensively.
Title: Clinical characteristics of patients with heart failure and intracardiac thrombus
Description:
BackgroundHeart failure (HF) patients are in a hypercoagulable state that predisposes them to an intracardiac thrombus.
We aim to assess the clinical features of patients with HF and intracardiac thrombus.
MethodsPatients diagnosed with HF with intracardiac thrombus were enrolled in this study.
Patients' demographics, clinical comorbidities, laboratory tests, and cardiac imaging parameters are recorded.
Baseline characteristics are described; the relationship between intracardiac thrombus location and cardiac underlying diseases, New York Heart Association (NYHA) class, and left ventricular ejection fraction (LVEF) are analyzed; and the anticoagulation rate is summarized.
ResultsA total of 1,248 patients were included in the study.
Most patients were men (72.
2%) with a mean age of 54 years.
The left ventricle is the most frequently involved (66.
8%), and the prevalence of left ventricular thrombus is more in patients complicated with coronary artery diseases, ventricular noncompaction cardiomyopathy, and dilated cardiomyopathy (86.
3%, 86.
4%, and 78.
2%, respectively).
When combined with atrial fibrillation, atrial flutter, hypertrophic cardiomyopathy, restrictive cardiomyopathy, or valvular cardiomyopathy, the intracardiac thrombus is mostly likely to occur in the left atrium.
The incidence rate of left cardiac thrombosis increased with the decline of LVEF, an increase of NYHA class, and enlargement of a cardiac chamber.
Overall, the anticoagulation rate was 56.
8%, with warfarin still the mainstay drug (45.
1%), while the prescription of non-vitamin K antagonist oral anticoagulants rose year by year.
As for imaging modalities for thrombus detection and diagnosis, transthoracic echocardiography was the most widely performed (75.
1%).
ConclusionThis study summarizes the underlying disease constitution, thrombus location and related factors, imaging modalities, and antithrombotic profile in HF patients with intracardiac thrombus comprehensively.

Related Results

Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
The value of thrombus markers applied in patients with respiratory failure
The value of thrombus markers applied in patients with respiratory failure
Background: This work assessed the value of novel thrombus markers-thrombin-antithrombin complex (TAT), plasmin-a2-plasmin inhibitor complex (PIC), thrombomodulin (TM), and tissue ...
Abstract TP217: Thrombus Migration in Acute Ischemic Stroke Patients Receiving Mechanical Thrombectomy
Abstract TP217: Thrombus Migration in Acute Ischemic Stroke Patients Receiving Mechanical Thrombectomy
Background: Thrombus migration is occasionally observed during mechanical thrombectomy in acute ischemic stroke patients. However, the factors influencing migration and...
Prediction of thrombus resolution after intravenous thrombolysis assessed by CT-based thrombus imaging
Prediction of thrombus resolution after intravenous thrombolysis assessed by CT-based thrombus imaging
SummaryThe degree of thrombus resolution directly indicates the effectiveness of a thrombolytic drug. We investigated the degree of thrombus resolution and factors associated with ...
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Etiology and predictors of heart failure in pregnancy. Newer Insights from the M-PAC registry
Abstract Background Women with heart disease undergoing pregnancy is on the increase, along with an increasing cardiac contribut...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract Introduction Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Emerging Evidence of IgG4-Related Disease in Pericarditis: A Systematic Review
Abstract Introduction Immunoglobulin G4-related disease (IgG4-RD) is a recently identified immune-mediated condition that is debilitating and often overlooked. While IgG4-RD has be...
Postprocessing Method for Enhanced Left Ventricular Thrombus Detection in Echocardiography
Postprocessing Method for Enhanced Left Ventricular Thrombus Detection in Echocardiography
Background and Objectives: The incidence of left ventricular thrombus has decreased in recent years due to advancements in reperfusion strategies for acute myocardial infarction an...

Back to Top